CRP levels in autoimmune disease can be specified by measurement of procalcitonin

被引:98
作者
Schwenger, V
Sis, J
Breitbart, A
Andrassy, K
机构
[1] Univ Heidelberg, Med Klin, D-69115 Heidelberg, Germany
[2] Med Poliklin Heidelberg, D-69115 Heidelberg, Germany
关键词
D O I
10.1007/BF02962246
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Autoimmune diseases (AID) are prone to infection particularly under immunosuppression. The differentiation of infection from active AID is often difficult. In order to specify; the diagnostic value of measurement of procalcitonin (PCT) in AID 81 patients with anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis were analyzed, 27 with rheumatoid arthritis and 25 patients with systemic lupus erythematosus at various stages of the disease. Although PCT levels (95th percentile) were below 0.5 ng/ml in patients with active systemic lupus erythematosus and rheumatoid arthritis, the cutoff for normal values (95th percentile) in patients with active ANCA-positive vasculitis was 0.89, Therefore PCT levels of < 1 ng/ml are recommended as cutoff for invasive infections in patients with ANCA-positive vasculitis. In view of the increased mortality under immunosuppression in patients with AID and additional bacterial infection the measurement of PCT is helpful when an infectious origin is suspected.
引用
收藏
页码:274 / 276
页数:3
相关论文
共 14 条
[1]   THE AMERICAN-RHEUMATISM-ASSOCIATION 1987 REVISED CRITERIA FOR THE CLASSIFICATION OF RHEUMATOID-ARTHRITIS [J].
ARNETT, FC ;
EDWORTHY, SM ;
BLOCH, DA ;
MCSHANE, DJ ;
FRIES, JF ;
COOPER, NS ;
HEALEY, LA ;
KAPLAN, SR ;
LIANG, MH ;
LUTHRA, HS ;
MEDSGER, TA ;
MITCHELL, DM ;
NEUSTADT, DH ;
PINALS, RS ;
SCHALLER, JG ;
SHARP, JT ;
WILDER, RL ;
HUNDER, GG .
ARTHRITIS AND RHEUMATISM, 1988, 31 (03) :315-324
[2]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[3]   DERIVATION OF THE SLEDAI - A DISEASE-ACTIVITY INDEX FOR LUPUS PATIENTS [J].
BOMBARDIER, C ;
GLADMAN, DD ;
UROWITZ, MB ;
CARON, D ;
CHANG, CH .
ARTHRITIS AND RHEUMATISM, 1992, 35 (06) :630-640
[4]   INFECTIOUS COMPLICATIONS OF CYCLOPHOSPHAMIDE TREATMENT FOR VASCULITIS [J].
BRADLEY, JD ;
BRANDT, KD ;
KATZ, BP .
ARTHRITIS AND RHEUMATISM, 1989, 32 (01) :45-53
[5]   PROCALCITONIN INCREASE AFTER ENDOTOXIN INJECTION IN NORMAL SUBJECTS [J].
DANDONA, P ;
NIX, D ;
WILSON, MF ;
ALJADA, A ;
LOVE, J ;
ASSICOT, M ;
BOHUON, C .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1605-1608
[6]   Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection [J].
Eberhard, OK ;
Haubitz, M ;
Brunkhorst, FM ;
Kliem, V ;
Koch, KM ;
Brunkhorst, R .
ARTHRITIS AND RHEUMATISM, 1997, 40 (07) :1250-1256
[7]   Procalcitonin, a marker of bacterial infection [J].
Gendrel, D ;
Bohuon, C .
INFECTION, 1997, 25 (03) :133-134
[8]   NOMENCLATURE OF SYSTEMIC VASCULITIDES - PROPOSAL OF AN INTERNATIONAL CONSENSUS CONFERENCE [J].
JENNETTE, JC ;
FALK, RJ ;
ANDRASSY, K ;
BACON, PA ;
CHURG, J ;
GROSS, WL ;
HAGEN, EC ;
HOFFMAN, GS ;
HUNDER, GG ;
KALLENBERG, CGM ;
MCCLUSKEY, RT ;
SINICO, RA ;
REES, AJ ;
VANES, LA ;
WALDHERR, R ;
WIIK, A .
ARTHRITIS AND RHEUMATISM, 1994, 37 (02) :187-192
[9]  
KARAZAI W, 1997, INFECTION, V25, P329
[10]  
LUQMANI RA, 1994, Q J MED, V87, P671